Provenienza dei contatti di primo grado di John Oates
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Opsidio LLC
Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John Oates tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
DVL, INC. | Finance/Rental/Leasing | Chief Executive Officer | |
PORTAGE BIOTECH INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Wayne State University (Michigan) | College/University | Doctorate Degree | |
Philabundance
Philabundance Services to the Health IndustryHealth Services Philabundance provides food services to the community. The company was founded in 1984 by Pamela Rainey Lawler and is headquartered in Philadelphia, PA. | Services to the Health Industry | Director/Board Member | |
The University of Texas at Austin | College/University | Corporate Officer/Principal | |
University of Michigan | College/University | Undergraduate Degree | |
Baylor College of Medicine | College/University | Corporate Officer/Principal | |
Zarwin, Baum, Devito, Kaplan, Schaer & Toddy P.C. | General Counsel | ||
Kenbee Management, Inc. | President | ||
P&A Associates
P&A Associates Real Estate DevelopmentFinance P&A Associates engages in the provision of real estate development services. It offers office, retail and industrial renovations. The company was founded by Alan E. Casnoff and Peter L. Shaw on July 1, 1977 and is headquartered in Philadelphia, PA. | Real Estate Development | Founder | |
Portage Pharma Ltd.
Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Miscellaneous Commercial Services | Chief Executive Officer | |
Portage Glasgow Ltd.
Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Pharmaceuticals: Major | Chief Executive Officer | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 15 |
Canada | 2 |
Settori
Health Technology | 7 |
Consumer Services | 5 |
Finance | 3 |
Commercial Services | 3 |
Health Services | 2 |
Posizioni
Director/Board Member | 9 |
Chief Tech/Sci/R&D Officer | 6 |
Chief Executive Officer | 4 |
President | 2 |
Corporate Officer/Principal | 2 |
Contatti più connessi
Insiders | |
---|---|
Martin Phillips | 9 |
Alan E. Casnoff | 6 |
Frank W. Marcoux | 5 |
Nicholas Lukacs | 1 |
- Borsa valori
- Insiders
- John Oates
- Connessioni Società